---
title: "Sermorelin: Dosing & Vendor Prices | BodyHackGuide"
url: https://www.bodyhackguide.co/compound/sermorelin
description: "Sermorelin: dosing protocols, mechanism & side effects, 198 PubMed results. Compare 4 current vendor prices."
lang: en
---

Skip to content

Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide)

Image: Sermorelin molecular structure (https://www.bodyhackguide.co/assets/peptide-structure-placeholder-DUmZBF_j.png)

# Sermorelin

Growth Hormone / IGF-1 Axis (https://www.bodyhackguide.co/wiki#cat-growth-hormone-/-igf-1-axis)FDA Approved

Also known as: GRF 1-29

Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29). It was one of the first GHRH analogs to achieve FDA approval — Geref received pediatric approval in 1997 for evaluating and treating idiopathic growth hormone deficiency in children.

Image: Ion Peptide logo (https://ionpeptide.com/wp-content/uploads/2025/08/ion-peptide-logo-1-300x148.jpg)

Lowest price per mg

$6.50/mg $65.00 for 10mg

at Ion Peptide ·

Buy at Ion Peptide: https://ionpeptide.com/product/sermorelin/?ref=reddit15

Half-life: ~10-20 minutes (plasma CAS: 86168-78-7 198 PubMed results (https://pubmed.ncbi.nlm.nih.gov/?term=sermorelin%20GHRH%20growth%20hormone)

Last reviewed: May 4, 2026

## Overview

### At A Glance

Mechanism

GHRH Receptor Pharmacology…

Half-Life

~10-20 minutes (plasma; native GHRH 7 minutes)

Potential Benefits

Natural GH pulse stimulation Improved sleep quality Enhanced recovery and body composition Anti-aging effects Better skin elasticity Increased lean muscle mass

Safety Notes

Common

Injection site redness/swelling Headache Flushing Nausea

### Mechanism of Action

### GHRH Receptor Pharmacology

Sermorelin is a truncated analog - the first 29 amino acids - of the 44-amino-acid native GHRH produced by the arcuate nucleus of the hypothalamus. The 1-29 fragment retains essentially the full growth-hormone-releasing activity of the parent hormone; the C-terminal residues 30-44 contribute to stability but are not required for receptor binding or activation [PMID:8772599].

When sermorelin binds the GHRH receptor (GHRHR) - a class B G-protein-coupled receptor expressed on anterior-pituitary somatotrophs - it triggers:

- **Gs-protein activation** increased cyclic AMP protein kinase A signaling
- **Transcription of the GH1 gene** and exocytosis of stored GH secretory granules
- **Synergy with the ghrelin/GHS-R1a pathway** when a growth-hormone secretagogue (e.g., ipamorelin) is co-administered

The net effect is a pulsatile release of the body's own growth hormone rather than the flat, supraphysiologic exposure produced by injecting recombinant HGH, which bypasses the pituitary entirely.

### Pulsatility and the Somatostatin Gate

GHRH-driven GH release remains **subject to somatostatin tone**. Somatostatin - released from the periventricular nucleus of the hypothalamus - sets a ceiling on how much GH any single GHRH pulse can elicit. This is why sermorelin cannot drive GH to the supraphysiologic levels achievable with exogenous HGH, and why it preserves the natural ultradian rhythm of GH secretion. Dose-response work in older men showed GH and IGF-1 output rise with dose and then plateau, consistent with this somatostatin ceiling [PMID:1379256].

### Short Half-Life as a Feature

Native GHRH has a plasma half-life of roughly 7 minutes; sermorelin clears with a half-life on the order of 10-20 minutes. This rapid clearance:

1. **Limits receptor desensitization** that continuous GHRH exposure would cause
2. **Allows somatostatin pulses** to suppress GH between cycles
3. **Reproduces the brief GHRH pulses** that occur naturally in young adults

This is also why sermorelin must be dosed daily, whereas long-acting analogs such as CJC-1295-DAC extend the dosing interval but sacrifice the pulsatile pharmacology.

### Downstream Effects

Nightly sermorelin (or the closely related GHRH(1-29) analogs used in trials) raises IGF-1 within the physiologic range rather than above it. In the main controlled adult trial, IGF-1 rose ~28% and skin thickness increased in both sexes, while lean-body-mass, insulin-sensitivity, general well-being and libido improvements were seen in men only [PMID:9141536][PMID:9360512]. Effects reported across the literature (with varying strength of evidence) include:

- Modest lean-mass gains and small reductions in body fat (male-predominant in the controlled data)
- A tendency toward improved slow-wave (NREM) sleep - GHRH is itself a sleep-regulatory peptide, and the largest physiologic GH pulse occurs during early slow-wave sleep
- Subjective improvements in recovery and skin quality

These should be read as **physiologic restoration** toward a more youthful GH secretion pattern - not the supraphysiologic anabolism of recombinant HGH or anabolic steroids. Notably, single-nightly dosing produced no measurable IGF-1 or body-composition change in one 6-week trial [PMID:9005976], so real-world response is variable and dosing schedule matters.

### Overview

Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29). It was one of the first GHRH analogs to achieve FDA approval — Geref received pediatric approval in 1997 for evaluating and treating idiopathic growth hormone deficiency in children. Although the branded product was discontinued commercially in 2008 due to market factors unrelated to safety or efficacy, sermorelin has experienced a significant second life through 503B compounding pharmacies that supply it for off-label use in adult growth hormone axis support, anti-aging medicine, and athletic performance contexts.

Sermorelin binds the GHRH receptor (GHRHR) on pituitary somatotrophs and triggers endogenous growth hormone release through the body's native negative-feedback architecture. Because it relies on pituitary reserve rather than bypassing it, sermorelin produces **pulsatile GH release that respects somatostatin inhibition** — you cannot overshoot the way exogenous recombinant human GH can, and IGF-1 typically rises into the upper quartile of age-adjusted normal rather than into supraphysiological territory. This is the fundamental mechanistic difference that makes GHRH therapy tolerable for long-term use where rhGH use carries more concerning risks.

Its short serum half-life — approximately **10 to 20 minutes** in healthy adults — is simultaneously sermorelin's greatest limitation and its most clinically elegant feature. The short window forces once-daily bedtime dosing that aligns with the body's natural nocturnal GH pulse, and it means residual peptide never persists long enough to disturb subsequent endogenous pulses. Modern practitioners frequently choose sermorelin over longer-acting analogs like CJC-1295 DAC specifically because the pulsatile kinetics more closely mimic healthy young physiology.

In research and clinical settings, sermorelin is typically dosed at **200 to 500 mcg subcutaneously at bedtime** for adult GH tuning protocols, though historical pediatric GHD protocols used up to 30 mcg/kg/day. Six-month trials in healthy older adults have demonstrated modest but measurable gains in lean body mass, reductions in visceral adiposity, and improvements in sleep architecture — particularly slow-wave sleep depth, which is where the majority of physiologic GH secretion occurs in the first place.

### Potential Research Fields

Growth hormone deficiency Anti-aging Body composition Pituitary function

## Chemical Information

IUPAC Name

Growth hormone-releasing hormone (1-29) amide

CAS Number

86168-78-7

Molecular Formula

C149H246N44O42S

Molecular Mass

3357.9 g/mol

Image: Sermorelin molecular structure (https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/16132104/PNG?image_size=300x300)

View on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/16132104

Amino Acid Sequence

YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 (29 residues; GHRH(1-29) with a C-terminal amide). Full sequence: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. Molecular formula C149H246N44O42S; molecular weight ~3357.9 g/mol.

## Dosing & Protocols

### Unlock the dosing protocols

Enter your email to keep reading. It is free, and it opens these tabs on every compound page in this browser.

- Dose, route, how often and how long
- A titration schedule
- Beginner, intermediate and advanced protocols
- Reconstitution and handling notes

You also get the free peptide cheat sheet by email. Unsubscribe anytime.

Have an account? Sign in (https://www.bodyhackguide.co/auth)

## Research

### Unlock the research summary

- A summary of the key research
- Safety and side effects
- A link to the PubMed results

## Interactions

### Interaction Matrix

### Contraindications

Sermorelin is contraindicated or requires extreme caution in:

- **Active malignancy** — particularly any hormone-responsive cancer (breast, prostate, endometrial) given the theoretical concern that elevated IGF-1 could promote tumor growth
- **Strong family history of GH-axis responsive cancers** — use only under specialist supervision with close monitoring
- **Pregnancy and lactation** — no established safety data; avoid
- **Known hypersensitivity** to sermorelin, GHRH analogs, or any excipient
- **Severe untreated sleep apnea** — theoretical concern about upper airway soft tissue growth; stabilize with CPAP/APAP before initiating
- **Acute critical illness** — GH-axis stimulation is inappropriate during sepsis, post-surgical recovery, multiple trauma, or respiratory failure states
- **Diabetic ketoacidosis or severe uncontrolled diabetes** — resolve the metabolic state first
- **Active proliferative retinopathy** — relative contraindication; discuss with ophthalmologist

**Relative cautions requiring monitoring:**

- Borderline fasting glucose or HbA1c — monitor closely; discontinue if deterioration
- History of benign adenomas (pituitary, adrenal, thyroid) — imaging surveillance recommended
- Strong family history of colon polyps — baseline colonoscopy before starting, surveillance per gastroenterology guidance
- Concurrent glucocorticoid therapy — pharmacodynamic interference; GH-axis stimulation is less effective in pharmacologic steroid contexts

**Age-related note:** Sermorelin has been used in pediatric GHD populations historically with FDA approval, but use in healthy older adults for anti-aging purposes remains off-label and should only be undertaken with informed consent about the limitations of available long-term safety data.

Research Disclaimer

This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

Best Price

$24.99

up to $65.00

Best $/mg

$6.5000

Vendors

4

Listings

8

vial

Dosage

Form

Sort

| Vendor | Product | Form | Qty | Price | $/mg | Coupon | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Image: Disguised Alpha logo (https://disguisedalpha.com/wp-content/themes/assets/logos/disguised-logo-2x.png) Disguised Alpha (https://www.bodyhackguide.co/vendors/disguised-alpha) 50: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🇪🇺 EU 🇬🇧 UK | Sermorelin Acetate | vial | 1 vial ● In Stock | $49.99 | — | — | Buy: https://disguisedalpha.com/product/sermorelin/?coupon=reddit |
| Image: Ion Peptide logo (https://ionpeptide.com/wp-content/uploads/2025/08/ion-peptide-logo-1-300x148.jpg) Ion Peptide (https://www.bodyhackguide.co/vendors/ion-peptide) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Sermorelin 5mg | vial | 1 vial ● Out of Stock | $39.00 | $7.80 | — | View: https://ionpeptide.com/product/sermorelin/?ref=reddit15 |
| Image: Ion Peptide logo (https://ionpeptide.com/wp-content/uploads/2025/08/ion-peptide-logo-1-300x148.jpg) Ion Peptide (https://www.bodyhackguide.co/vendors/ion-peptide) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Sermorelin 10mg | vial | 1 vial ● In Stock | $65.00 VALUE | $6.50 | — | Buy: https://ionpeptide.com/product/sermorelin/?ref=reddit15 |
| Image: Ion Peptide logo (https://ionpeptide.com/wp-content/uploads/2025/08/ion-peptide-logo-1-300x148.jpg) Ion Peptide (https://www.bodyhackguide.co/vendors/ion-peptide) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Sermorelin 15mg | vial | 1 vial ● Out of Stock | $85.00 | $5.67 | — | View: https://ionpeptide.com/product/sermorelin/?ref=reddit15 |
| Image: BioMyst Labs logo (https://biomystlabs.com/wp-content/uploads/2025/12/Asset-36@3x-scaled.png) BioMyst Labs (https://www.bodyhackguide.co/vendors/biomyst-labs) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Sermorelin 5mg | vial | 1 vial ● In Stock | $34.99 | $7.00 | — | Buy: https://biomystlabs.com/product/sermorelin-5mg/?ref=rxtkqorwv |
| Image: BioMyst Labs logo (https://biomystlabs.com/wp-content/uploads/2025/12/Asset-36@3x-scaled.png) BioMyst Labs (https://www.bodyhackguide.co/vendors/biomyst-labs) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Sermorelin 5mg | vial | 1 vial ● In Stock | $39.99 | $8.00 | — | Buy: https://biomystlabs.com/product/sermorelin-5mg/?ref=rxtkqorwv |
| Image: VANDL Labs logo (https://halfnattys.shop/wp-content/themes/halfnattys/assets/img/logo.webp) VANDL Labs (https://www.bodyhackguide.co/vendors/vandl-labs) 50: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US | Sermorelin 2mg | vial | 2mg vial ● In Stock | $24.99 BEST | $12.49 | CHON | Buy: https://www.vandl-labs.com/product/sermorelin/?ref=choncho |
| Image: VANDL Labs logo (https://halfnattys.shop/wp-content/themes/halfnattys/assets/img/logo.webp) VANDL Labs (https://www.bodyhackguide.co/vendors/vandl-labs) 50: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US | Sermorelin 5mg | vial | 5mg vial ● In Stock | $39.99 | $8.00 | CHON | Buy: https://www.vandl-labs.com/product/sermorelin/?ref=choncho |

### Sign in to leave a review

Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Sermorelin.

Current low

$24.99

current listings

7-day low

—

not enough history yet

30-day low

—

not enough history yet

30-day change

—

not enough history yet

Tracking since Mar 13, 2026 · 7 data points

## Price History

4 data points

### Vendors Selling Sermorelin

#### VANDL Labs

2 listings · from $24.99
https://www.bodyhackguide.co/vendors/vandl-labs

#### BioMyst Labs

4.5

2 listings · from $34.99
https://www.bodyhackguide.co/vendors/biomyst-labs

#### Ion Peptide

4.5

3 listings · from $39.00
https://www.bodyhackguide.co/vendors/ion-peptide

#### Disguised Alpha

1 listing · from $49.99
https://www.bodyhackguide.co/vendors/disguised-alpha

How we score these vendors

Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank.

View Scorecard (https://www.bodyhackguide.co/vendors/scorecard)

### Related Compounds

View All (https://www.bodyhackguide.co/wiki)

### CJC-1295 (Mod GRF 1-29)

Growth Hormone / IGF-1 Axis Preclinical

CJC-1295 without DAC (also called Modified GRF 1-29 or MOD-GRF 1-29) is a 30-amino-acid analog of the first 29 residues of endogenous Growth Hormone Releasing Hormone (GHRH), with four strategic substitutions (D-Ala² for DPP-4 resistance, Gln⁸, Ala¹⁵, Leu²⁷) that extend its plasma half-life from <2 minutes (native GHRH) to ~30 minutes.

t½ ~30 minutes (without DAC / MOD-GRF 1-29); ~6-8 days (with DAC, due to covalent albumin binding) Without DAC: 100-300 mcg subcutaneous 1-3x daily (typically pre-bedtime); With DAC: 1000-2000 mcg subcutaneous once weekly

29 PubMed View Profile
https://www.bodyhackguide.co/compound/cjc-1295

### CJC-1295 with DAC

Growth Hormone / IGF-1 Axis Preclinical / Research peptide

CJC-1295 with DAC is the long-acting variant of CJC-1295.

t½ ~6-8 days (DAC-bound albumin depot) 1000-2000 mcg (1-2 mg) per week

Preclinical View Profile
https://www.bodyhackguide.co/compound/cjc-1295-with-dac

### CJC-1295 with DAC

Growth Hormone / IGF-1 Axis Phase 2

CJC-1295 with DAC (Drug Affinity Complex) is a modified form of CJC-1295 that incorporates a maleimidopropionic acid (MPA) reactive group at the C-terminus.

t½ 6–8 days (due to albumin binding via DAC) 1,000–2,000 mcg (1–2 mg) per injection

Preclinical View Profile
https://www.bodyhackguide.co/compound/cjc-1295-dac

### GHRP-2

Growth Hormone / IGF-1 Axis Phase 2

GHRP-2 (growth hormone-releasing peptide-2), also known as pralmorelin and KP-102, is a synthetic hexapeptide growth hormone secretagogue that was among the first GHRPs developed in the seminal research of Cyril Bowers and colleagues at Tulane University in the late 1980s and early 1990s.

t½ ~15-30 minutes 100–300 mcg per injection

212 PubMed View Profile
https://www.bodyhackguide.co/compound/ghrp-2

### GHRP-6

Growth Hormone / IGF-1 Axis Phase 2

GHRP-6 (growth hormone-releasing peptide-6) is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 that binds the ghrelin receptor (GHS-R1a) to stimulate endogenous growth hormone release.

t½ ~20–30 minutes 100–300 mcg per injection

156 PubMed View Profile
https://www.bodyhackguide.co/compound/ghrp-6

### Hexarelin

Growth Hormone / IGF-1 Axis Phase 2

Hexarelin (also called examorelin) is a potent synthetic hexapeptide growth hormone secretagogue with the sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2.

t½ ~55 minutes (IV, per Imbimbo 1994) 100–200 mcg per injection

14 PubMed View Profile
https://www.bodyhackguide.co/compound/hexarelin

### Side-by-Side Comparisons

All Comparisons (https://www.bodyhackguide.co/compare)

Sermorelin vs Ipamorelin: https://www.bodyhackguide.co/compare/sermorelin-vs-ipamorelin
Sermorelin vs Tesamorelin: https://www.bodyhackguide.co/compare/tesamorelin-vs-sermorelin
Sermorelin vs CJC-1295 (Mod GRF 1-29): https://www.bodyhackguide.co/compare/cjc-1295-vs-sermorelin

View Full Dosage Guide →

Protocols, calculator & safety for Sermorelin
https://www.bodyhackguide.co/guides/dosage/sermorelin

### Related Articles

All Posts (https://www.bodyhackguide.co/blog)

#### The 8 Best Peptide Companies for Research: 2026 Purity & Price Comparison

A data-driven comparison of every active peptide vendor we track: COA audit results, price-per-mg tables for 19 compounds, and a step-by-step purchase guide.

9/16/2026
https://www.bodyhackguide.co/blog/best-peptide-companies-2026

#### The Complete Peptide Reconstitution Guide (2026): Ratios, Math, and Common Mistakes

The master reconstitution reference for 17 peptides. BAC vs SWFI vs acetic acid, mg/mL targets, IU math on U100 syringes, storage and stability by peptide class, sterile technique, and the mistakes that destroy $60 vials. Includes worked examples for BPC-157, TB-500, GHK-Cu, semaglutide, tirzepatide, CJC-1295, ipamorelin, sermorelin, GHRPs, Melanotan II, PT-141, oxytocin, Semax, Selank, DSIP, and epithalon.

4/21/2026
https://www.bodyhackguide.co/blog/complete-peptide-reconstitution-guide-2026

### Lowest Price per mg

Ion Peptide

$65.00($6.50/mg)

4 vendors · 8 listings

### Research Score

80

198 PubMed results

### Quality Indicators

Data Completeness

100%

Description

Mechanism of Action

Chemical Data

Dosing Protocols

Safety Profile

PubMed Results

Interactions

Vendor Listings

Research Volume

198 PubMed results

Well-researched compound

### Quick Facts

Half-Life

Molecular Weight

3357.9 g/mol

CAS Number

86168-78-7

Trial Phase

FDA Approved

### Safety Profile

Low Risk

Common Side Effects

- • Injection site redness/swelling
- • Headache
- • Flushing
- • Nausea

Stop Use If

- Active malignancy
- Hypothyroidism (treat first)
- Pituitary tumor

Research Disclaimer

This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.

## Frequently Asked Questions

What is sermorelin and how does it work?

Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of GHRH - the hypothalamic hormone that tells your pituitary to release growth hormone. It binds the GHRH receptor on pituitary somatotrophs, triggering a pulsatile release of endogenous GH that respects the body's natural negative feedback architecture. It was originally FDA-approved as Geref in 1997 for pediatric growth hormone deficiency evaluation and treatment, and is now commonly used off-label through 503B compounding pharmacies for adult GH optimization. Unlike recombinant HGH, sermorelin cannot produce supraphysiologic GH levels because somatostatin limits how much GH any single GHRH pulse can elicit.

How is sermorelin different from CJC-1295?

Sermorelin is pure GHRH(1-29) with a 10-20 minute half-life. CJC-1295 without DAC is a stabilized GHRH analog with a modestly longer half-life (~30 minutes), and CJC-1295 DAC adds a DAC linker that extends half-life to ~8 days. Sermorelin and no-DAC CJC-1295 produce pulsatile GH release; CJC-1295 DAC produces continuous GHRH-receptor stimulation that raises baseline GH and IGF-1 more dramatically but eliminates pulsatility. For users prioritizing the most physiologic secretion pattern and minimum receptor desensitization risk, sermorelin is the most conservative choice. For users prioritizing convenience (once or twice weekly dosing), CJC-1295 DAC wins. See the CJC-1295 page (https://www.bodyhackguide.co/compound/cjc-1295) for a detailed side-by-side.

What results should I expect from sermorelin?

Be realistic - the controlled human data are modest. In the main adult trial of GHRH(1-29) (Khorram 1997), IGF-1 rose about 28% and skin thickness increased in both sexes, but lean body mass and quality-of-life gains appeared in men only, and a separate 6-week trial of single nightly dosing found no IGF-1 or body-composition change at all. So expect a modest IGF-1 rise into the upper-normal range, possibly small improvements in body composition, recovery, sleep depth and skin quality over 12-16 weeks, and nothing resembling recombinant HGH or anabolic steroids. Sermorelin is best understood as nudging your own GH secretion back toward a more youthful pattern rather than delivering supraphysiologic GH. Individual response varies widely.

What is the best sermorelin dosage?

The typical adult protocol is 200-500 mcg subcutaneously once nightly at bedtime. Beginners start at 200-300 mcg to assess tolerance. After 6-12 weeks, responders typically titrate to 300-500 mcg based on IGF-1 response. The single-dose ceiling is around 500 mcg - above that, somatostatin tone prevents further GH release, so higher doses are simply wasted peptide. Some advanced users split the dose into a morning and evening injection, though the bedtime-only approach remains the most common and best-studied. Always dose in a fasted state (3+ hours after last meal) to avoid the insulin-driven somatostatin surge that would blunt GH release.

Can I stack sermorelin with ipamorelin?

Yes - sermorelin + ipamorelin is the classic and most well-established GHRH + GHS combination in the peptide space. The two compounds bind different receptors on the same pituitary somatotrophs (GHRHR and GHS-R1a respectively) and produce a 3-5x amplification of GH pulse amplitude compared to either compound alone (Bowers 1991). Typical stack dose is sermorelin 200-300 mcg + ipamorelin 200-300 mcg in the same subcutaneous injection at bedtime. Ipamorelin's selectivity - it does not elevate cortisol, prolactin, or ACTH - makes it the cleanest ghrelin mimetic to pair with sermorelin. See ipamorelin (https://www.bodyhackguide.co/compound/ipamorelin) for full details.

Is sermorelin still FDA approved?

Sermorelin acetate received FDA approval in 1997 as Geref for evaluation of pediatric growth hormone deficiency. The branded product was discontinued commercially in 2008 due to market factors - not safety or efficacy concerns. The peptide itself remains legally available through 503B compounding pharmacies that produce it for physicians who prescribe it off-label for adult GH optimization. This legal-but-compounded status is similar to many other legacy peptides. Clinical use is supervised by medical professionals, and the quality-controlled compounded version is considered equivalent to the original Geref for pharmacologic purposes.

How long does it take sermorelin to work?

The GH and IGF-1 response to a single sermorelin injection occurs within minutes - peak serum GH typically occurs 15-30 minutes post-injection. However, the clinically meaningful body composition and subjective effects take 6-16 weeks of consistent nightly dosing to become apparent. IGF-1 stabilizes at its new elevated setpoint around week 4-6. Lean body mass changes are detectable by week 8-12. Sleep quality improvements often show up earliest - many users report enhanced slow-wave sleep within 2-3 weeks of consistent dosing. Skin changes (improved thickness, hydration) take 12-16 weeks to measure but are usually subjectively noticed earlier.

What are the side effects of sermorelin?

Most side effects are mild and transient. The most common are injection site reactions (erythema, mild itching), facial flushing immediately after injection (fades within 10-20 minutes), and occasionally vivid dreams - which isn't necessarily adverse given that sermorelin improves slow-wave sleep where dreams are consolidated. Less common effects include mild headache, transient hunger (less pronounced than with ghrelin mimetics), and minor fluid retention in the first weeks. Theoretical long-term concerns relate to sustained IGF-1 elevation and cancer risk, though no causal link has been demonstrated in trials to date. Stop if you develop persistent joint pain, carpal tunnel symptoms, or peripheral edema - these suggest IGF-1 is too high.

Does sermorelin cause weight loss?

Sermorelin is not primarily a weight-loss compound. It produces modest reductions in visceral and subcutaneous fat over 12-16 weeks - typically 1-3% body fat in responders - alongside lean mass gains of similar magnitude. Users looking for dramatic weight loss should consider GLP-1 receptor agonists like semaglutide (https://www.bodyhackguide.co/compound/semaglutide), tirzepatide (https://www.bodyhackguide.co/compound/tirzepatide), or retatrutide (https://www.bodyhackguide.co/compound/retatrutide). Sermorelin is better understood as a body-composition-optimization tool that modestly improves the fat-to-lean ratio rather than a fat-loss drug. If visceral adiposity specifically is the target, tesamorelin (https://www.bodyhackguide.co/compound/tesamorelin) has FDA-approved trial data showing roughly 18% VAT reduction over 26 weeks, which is substantially more aggressive than sermorelin achieves.

Where can I buy sermorelin legally?

In the United States, sermorelin can be prescribed legally by licensed physicians and dispensed through 503B compounding pharmacies. This is the proper legal pathway - the prescribing physician oversees dosing, labs, and safety monitoring. There is also a gray-market research-chemical supply chain outside of medical oversight, but this path carries significant quality-control, sterility, and legal risk. Prescribed compounded sermorelin through a qualified clinic is the only path we recommend. For a curated list of peptide-friendly clinical practices and reliable compounded-peptide pharmacies, see our best vendors guide for 2026 (https://www.bodyhackguide.co/guides/best-vendors-2026).

## Research Tools

### Peptide Calculator

Reconstitution & syringe units
https://www.bodyhackguide.co/tools/reconstitution

### Reconstitution Guide

How to mix, step by step
https://www.bodyhackguide.co/guides/how-to-reconstitute-peptides

### Nasal Spray Calc

mL per actuation
https://www.bodyhackguide.co/tools/intranasal

### Half-Life Visualizer

Decay curves
https://www.bodyhackguide.co/tools/halflife

## Related Compounds

### CJC-1295 (Mod GRF 1-29)

Growth Hormone / IGF-1 Axis Preclinical

### CJC-1295 with DAC

### CJC-1295 with DAC

Growth Hormone / IGF-1 Axis Phase 2

### GHRP-2

Growth Hormone / IGF-1 Axis Phase 2

### GHRP-6

Growth Hormone / IGF-1 Axis Phase 2

### Hexarelin

Growth Hormone / IGF-1 Axis Phase 2

## Side-by-Side Comparisons

Compare Sermorelin head-to-head: mechanism, half-life, dosing, safety, and vendor prices.

Free 2026 Peptide Cheat Sheet (PDF)

38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.

Download Free (https://www.bodyhackguide.co/guides/peptide-cheat-sheet-download)

### Need bloodwork before starting?

Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.

Image: BodyHackGuide (https://www.bodyhackguide.co/assets/bodyhackguide-logo-DOzZNUyh.webp)

### BodyHackGuide

Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews.

support@bodyhackguide.co

Join our Discord: https://discord.gg/Mhq5UdRYBA
r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide

#### Explore

- Compare prices: https://www.bodyhackguide.co/compare
- Vendors: https://www.bodyhackguide.co/vendors
- Deals: https://www.bodyhackguide.co/deals
- Coupons: https://www.bodyhackguide.co/coupons
- Nootropics: https://www.bodyhackguide.co/nootropics
- Brain health: https://www.bodyhackguide.co/brain-health
- Blog: https://www.bodyhackguide.co/blog
- Guides: https://www.bodyhackguide.co/guides

#### Tools

- Reconstitution: https://www.bodyhackguide.co/tools/reconstitution
- Half-life visualizer: https://www.bodyhackguide.co/tools/halflife
- COA reader: https://www.bodyhackguide.co/tools/coa
- Cost calculator: https://www.bodyhackguide.co/tools/cost-calculator
- Stack builder: https://www.bodyhackguide.co/stack-builder
- All tools: https://www.bodyhackguide.co/tools

#### Trust & vendors

- Vendor directory: https://www.bodyhackguide.co/vendors
- Trust scorecard: https://www.bodyhackguide.co/vendors/scorecard
- Vendor trust badge: https://www.bodyhackguide.co/vendors/get-vetted
- Scoring methodology: https://www.bodyhackguide.co/vendors/methodology
- Peptide cheat sheet: https://www.bodyhackguide.co/guides/peptide-cheat-sheet-download

#### Company

- About: https://www.bodyhackguide.co/about
- Affiliate disclosure: https://www.bodyhackguide.co/affiliate-disclosure
- Editorial standards: https://www.bodyhackguide.co/editorial-standards
- Creators: https://www.bodyhackguide.co/creators
- Coaches: https://www.bodyhackguide.co/coaches
- 1-on-1 coaching: https://www.bodyhackguide.co/coaching
- Privacy: https://www.bodyhackguide.co/privacy
- Terms: https://www.bodyhackguide.co/terms
- Full site directory: https://www.bodyhackguide.co/site-directory

**Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology), and we earn a commission from purchases made through some of our links at no extra cost to you. Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure).

**Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations.

© 2026 BodyHackGuide. All rights reserved. · Terms (https://www.bodyhackguide.co/terms) · Privacy (https://www.bodyhackguide.co/privacy)

## Structured data

```json
[
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {
        "@type": "ListItem",
        "position": 1,
        "name": "Home",
        "item": "https://www.bodyhackguide.co/"
      },
      {
        "@type": "ListItem",
        "position": 2,
        "name": "Compounds",
        "item": "https://www.bodyhackguide.co/compare"
      },
      {
        "@type": "ListItem",
        "position": 3,
        "name": "Sermorelin"
      }
    ]
  },
  {
    "@context": "https://schema.org",
    "@type": "Product",
    "name": "Sermorelin",
    "description": "Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29). It was one of the first GHRH analogs to achieve FDA approval — Geref received pediatric approval in 1997 for evaluating and treating idiopathic growth hormone deficiency in children. Although the branded product was discontinued commercially in 2008 due to market factors unrelated to safety or efficacy, sermorelin has experienced a significant second life through 503B compounding pharmacies that supply it for off-label use in adult growth hormone axis support, anti-aging medicine, and athletic performance contexts. Sermorelin binds the GHRH receptor (GHRHR) on pituitary somatotrophs and triggers endogenous growth hormone release through the body's native negative-feedback architecture. Because it relies on pituitary reserve rather than bypassing it, sermorelin produces pulsatile GH release that respects somatostatin inhibition — you cannot overshoot the way exogenous recombinant human GH can, and IGF-1 typically rises into the upper quartile of age-adjusted normal rather than into supraphysiological territory. This is the fundamental mechanistic difference that makes GHRH therapy tolerable for long-term use where rhGH use carries more concerning risks. Its short serum half-life — approximately 10 to 20 minutes in healthy adults — is simultaneously sermorelin's greatest limitation and its most clinically elegant feature. The short window forces once-daily bedtime dosing that aligns with the body's natural nocturnal GH pulse, and it means residual peptide never persists long enough to disturb subsequent endogenous pulses. Modern practitioners frequently choose sermorelin over longer-acting analogs like CJC-1295 DAC specifically because the pulsatile kinetics more closely mimic healthy young physiology. In research and clinical settings, sermorelin is typically dosed at 200 to 500 mcg subcutaneously at bedtime for adult GH tuning protocols, though historical pediatric GHD protocols used up to 30 mcg/kg/day. Six-month trials in healthy older adults have demonstrated modest but measurable gains in lean body mass, reductions in visceral adiposity, and improvements in sleep architecture — particularly slow-wave sleep depth, which is where the majority of physiologic GH secretion occurs in the first place.",
    "url": "https://www.bodyhackguide.co/compound/sermorelin",
    "image": "https://www.bodyhackguide.co/og-image.png",
    "brand": {
      "@type": "Brand",
      "name": "Research Compound"
    },
    "offers": {
      "@type": "AggregateOffer",
      "lowPrice": "24.99",
      "highPrice": "65.00",
      "priceCurrency": "USD",
      "offerCount": "6",
      "availability": "https://schema.org/InStock",
      "offers": [
        {
          "@type": "Offer",
          "price": "24.99",
          "priceCurrency": "USD",
          "availability": "https://schema.org/InStock",
          "itemCondition": "https://schema.org/NewCondition",
          "url": "https://www.vandl-labs.com/product/sermorelin/?ref=choncho",
          "seller": {
            "@type": "Organization",
            "name": "VANDL Labs",
            "url": "https://www.vandl-labs.com/?ref=choncho"
          },
          "name": "Sermorelin 2mg vial"
        },
        {
          "@type": "Offer",
          "price": "34.99",
          "priceCurrency": "USD",
          "availability": "https://schema.org/InStock",
          "itemCondition": "https://schema.org/NewCondition",
          "url": "https://biomystlabs.com/product/sermorelin-5mg/?ref=rxtkqorwv",
          "seller": {
            "@type": "Organization",
            "name": "BioMyst Labs",
            "url": "https://biomystlabs.com"
          },
          "name": "Sermorelin 5mg vial"
        },
        {
          "@type": "Offer",
          "price": "39.99",
          "priceCurrency": "USD",
          "availability": "https://schema.org/InStock",
          "itemCondition": "https://schema.org/NewCondition",
          "url": "https://biomystlabs.com/product/sermorelin-5mg/?ref=rxtkqorwv",
          "seller": {
            "@type": "Organization",
            "name": "BioMyst Labs",
            "url": "https://biomystlabs.com"
          },
          "name": "Sermorelin 5mg vial"
        },
        {
          "@type": "Offer",
          "price": "39.99",
          "priceCurrency": "USD",
          "availability": "https://schema.org/InStock",
          "itemCondition": "https://schema.org/NewCondition",
          "url": "https://www.vandl-labs.com/product/sermorelin/?ref=choncho",
          "seller": {
            "@type": "Organization",
            "name": "VANDL Labs",
            "url": "https://www.vandl-labs.com/?ref=choncho"
          },
          "name": "Sermorelin 5mg vial"
        },
        {
          "@type": "Offer",
          "price": "49.99",
          "priceCurrency": "USD",
          "availability": "https://schema.org/InStock",
          "itemCondition": "https://schema.org/NewCondition",
          "url": "https://disguisedalpha.com/product/sermorelin/?coupon=reddit",
          "seller": {
            "@type": "Organization",
            "name": "Disguised Alpha",
            "url": "https://disguisedalpha.com/?coupon=reddit"
          }
        },
        {
          "@type": "Offer",
          "price": "65.00",
          "priceCurrency": "USD",
          "availability": "https://schema.org/InStock",
          "itemCondition": "https://schema.org/NewCondition",
          "url": "https://ionpeptide.com/product/sermorelin/?ref=reddit15",
          "seller": {
            "@type": "Organization",
            "name": "Ion Peptide",
            "url": "https://ionpeptide.com"
          },
          "name": "Sermorelin 10mg vial"
        }
      ]
    }
  },
  {
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "name": "Sermorelin",
    "description": "Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29). It was one of the first GHRH analogs to achieve FDA approval — Geref received pediatric approval in 1997 for evaluating and treating idiopathic growth hormone deficiency in children. Although the branded product was discontinued commercially in 2008 due to market factors unrelated to safety or efficacy, sermorelin has experienced a significant second life through 503B compounding pharmacies that supply it for off-label use in adult growth hormone axis support, anti-aging medicine, and athletic performance contexts. Sermorelin binds the GHRH receptor (GHRHR) on pituitary somatotrophs and triggers endogenous growth hormone release through the body's native negative-feedback architecture. Because it relies on pituitary reserve rather than bypassing it, sermorelin produces pulsatile GH release that respects somatostatin inhibition — you cannot overshoot the way exogenous recombinant human GH can, and IGF-1 typically rises into the upper quartile of age-adjusted normal rather than into supraphysiological territory. This is the fundamental mechanistic difference that makes GHRH therapy tolerable for long-term use where rhGH use carries more concerning risks. Its short serum half-life — approximately 10 to 20 minutes in healthy adults — is simultaneously sermorelin's greatest limitation and its most clinically elegant feature. The short window forces once-daily bedtime dosing that aligns with the body's natural nocturnal GH pulse, and it means residual peptide never persists long enough to disturb subsequent endogenous pulses. Modern practitioners frequently choose sermorelin over longer-acting analogs like CJC-1295 DAC specifically because the pulsatile kinetics more closely mimic healthy young physiology. In research and clinical settings, sermorelin is typically dosed at 200 to 500 mcg subcutaneously at bedtime for adult GH tuning protocols, though historical pediatric GHD protocols used up to 30 mcg/kg/day. Six-month trials in healthy older adults have demonstrated modest but measurable gains in lean body mass, reductions in visceral adiposity, and improvements in sleep architecture — particularly slow-wave sleep depth, which is where the majority of physiologic GH secretion occurs in the first place.",
    "lastReviewed": "2026-05-04T11:35:06.02+00:00",
    "url": "https://www.bodyhackguide.co/compound/sermorelin",
    "author": {
      "@type": "Person",
      "name": "BioChonch",
      "url": "https://www.bodyhackguide.co/about",
      "jobTitle": "Founder & Lead Researcher",
      "sameAs": [
        "https://reddit.com/r/BodyHackGuide",
        "https://reddit.com/r/BrainHackGuide",
        "https://reddit.com/r/Biohackingher"
      ],
      "worksFor": {
        "@type": "Organization",
        "name": "BodyHackGuide",
        "url": "https://www.bodyhackguide.co"
      }
    },
    "reviewedBy": {
      "@type": "Person",
      "name": "BioChonch",
      "url": "https://www.bodyhackguide.co/about",
      "jobTitle": "Founder & Lead Researcher",
      "sameAs": [
        "https://reddit.com/r/BodyHackGuide",
        "https://reddit.com/r/BrainHackGuide",
        "https://reddit.com/r/Biohackingher"
      ],
      "worksFor": {
        "@type": "Organization",
        "name": "BodyHackGuide",
        "url": "https://www.bodyhackguide.co"
      }
    },
    "publisher": {
      "@type": "Organization",
      "name": "BodyHackGuide",
      "url": "https://www.bodyhackguide.co"
    },
    "mainContentOfPage": {
      "@type": "WebPageElement",
      "cssSelector": "main"
    },
    "about": {
      "@type": "Drug",
      "name": "Sermorelin",
      "alternateName": [
        "GRF 1-29"
      ],
      "description": "Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29). It was one of the first GHRH analogs to achieve FDA approval — Geref received pediatric approval in 1997 for evaluating and treating idiopathic growth hormone deficiency in children. Although the branded product was discontinued commercially in 2008 due to market factors unrelated to safety or efficacy, sermorelin has experienced a significant second life through 503B compounding pharmacies that supply it for off-label use in adult growth hormone axis support, anti-aging medicine, and athletic performance contexts. Sermorelin binds the GHRH receptor (GHRHR) on pituitary somatotrophs and triggers endogenous growth hormone release through the body's native negative-feedback architecture. Because it relies on pituitary reserve rather than bypassing it, sermorelin produces pulsatile GH release that respects somatostatin inhibition — you cannot overshoot the way exogenous recombinant human GH can, and IGF-1 typically rises into the upper quartile of age-adjusted normal rather than into supraphysiological territory. This is the fundamental mechanistic difference that makes GHRH therapy tolerable for long-term use where rhGH use carries more concerning risks. Its short serum half-life — approximately 10 to 20 minutes in healthy adults — is simultaneously sermorelin's greatest limitation and its most clinically elegant feature. The short window forces once-daily bedtime dosing that aligns with the body's natural nocturnal GH pulse, and it means residual peptide never persists long enough to disturb subsequent endogenous pulses. Modern practitioners frequently choose sermorelin over longer-acting analogs like CJC-1295 DAC specifically because the pulsatile kinetics more closely mimic healthy young physiology. In research and clinical settings, sermorelin is typically dosed at 200 to 500 mcg subcutaneously at bedtime for adult GH tuning protocols, though historical pediatric GHD protocols used up to 30 mcg/kg/day. Six-month trials in healthy older adults have demonstrated modest but measurable gains in lean body mass, reductions in visceral adiposity, and improvements in sleep architecture — particularly slow-wave sleep depth, which is where the majority of physiologic GH secretion occurs in the first place.",
      "activeIngredient": "Sermorelin",
      "mechanismOfAction": "GHRH Receptor Pharmacology Sermorelin is a truncated analog - the first 29 amino acids - of the 44-amino-acid native GHRH produced by the arcuate nucleus of the hypothalamus. The 1-29 fragment retains essentially the full growth-hormone-releasing activity of the parent hormone; the C-terminal residues 30-44 contribute to stability but are not required for receptor binding or activation [PMID:8772599]. When sermorelin binds the GHRH receptor (GHRHR) - a class B G-protein-coupled receptor expressed on anterior-pituitary somatotrophs - it triggers: Gs-protein activation increased cyclic AMP protein kinase A signaling Transcription of the GH1 gene and exocytosis of stored GH secretory granules Synergy with the ghrelin/GHS-R1a pathway when a growth-hormone secretagogue (e.g., ipamorelin) is co-administered The net effect is a pulsatile release of the body's own growth hormone rather than the flat, supraphysiologic exposure produced by injecting recombinant HGH, which bypasses the pituitary entirely. Pulsatility and the Somatostatin Gate GHRH-driven GH release remains subject to somatostatin tone. Somatostatin - released from the periventricular nucleus of the hypothalamus - sets a ceiling on how much GH any single GHRH pulse can elicit. This is why sermorelin cannot drive GH to the supraphysiologic levels achievable with exogenous HGH, and why it preserves the natural ultradian rhythm of GH secretion. Dose-response work in older men showed GH and IGF-1 output rise with dose and then plateau, consistent with this somatostatin ceiling [PMID:1379256]. Short Half-Life as a Feature Native GHRH has a plasma half-life of roughly 7 minutes; sermorelin clears with a half-life on the order of 10-20 minutes. This rapid clearance: Limits receptor desensitization that continuous GHRH exposure would cause Allows somatostatin pulses to suppress GH between cycles Reproduces the brief GHRH pulses that occur naturally in young adults This is also why sermorelin must be dosed daily, whereas long-acting analogs such as CJC-1295-DAC extend the dosing interval but sacrifice the pulsatile pharmacology. Downstream Effects Nightly sermorelin (or the closely related GHRH(1-29) analogs used in trials) raises IGF-1 within the physiologic range rather than above it. In the main controlled adult trial, IGF-1 rose ~28% and skin thickness increased in both sexes, while lean-body-mass, insulin-sensitivity, general well-being and libido improvements were seen in men only PMID:9141536. Effects reported across the literature (with varying strength of evidence) include: Modest lean-mass gains and small reductions in body fat (male-predominant in the controlled data) A tendency toward improved slow-wave (NREM) sleep - GHRH is itself a sleep-regulatory peptide, and the largest physiologic GH pulse occurs during early slow-wave sleep Subjective improvements in recovery and skin quality These should be read as physiologic restoration toward a more youthful GH secretion pattern - not the supraphysiologic anabolism of recombinant HGH or anabolic steroids. Notably, single-nightly dosing produced no measurable IGF-1 or body-composition change in one 6-week trial [PMID:9005976], so real-world response is variable and dosing schedule matters.",
      "dosageForm": "vial",
      "legalStatus": "Not approved for human use (research chemical)",
      "warning": "For research purposes only. Not for human consumption."
    }
  },
  {
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
      {
        "@type": "Question",
        "name": "What is sermorelin and how does it work?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of GHRH - the hypothalamic hormone that tells your pituitary to release growth hormone. It binds the GHRH receptor on pituitary somatotrophs, triggering a pulsatile release of endogenous GH that respects the body's natural negative feedback architecture. It was originally FDA-approved as Geref in 1997 for pediatric growth hormone deficiency evaluation and treatment, and is now commonly used off-label through 503B compounding pharmacies for adult GH optimization. Unlike recombinant HGH, sermorelin cannot produce supraphysiologic GH levels because somatostatin limits how much GH any single GHRH pulse can elicit."
        }
      },
      {
        "@type": "Question",
        "name": "How is sermorelin different from CJC-1295?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Sermorelin is pure GHRH(1-29) with a 10-20 minute half-life. CJC-1295 without DAC is a stabilized GHRH analog with a modestly longer half-life (~30 minutes), and CJC-1295 DAC adds a DAC linker that extends half-life to ~8 days. Sermorelin and no-DAC CJC-1295 produce pulsatile GH release; CJC-1295 DAC produces continuous GHRH-receptor stimulation that raises baseline GH and IGF-1 more dramatically but eliminates pulsatility. For users prioritizing the most physiologic secretion pattern and minimum receptor desensitization risk, sermorelin is the most conservative choice. For users prioritizing convenience (once or twice weekly dosing), CJC-1295 DAC wins. See the CJC-1295 page for a detailed side-by-side."
        }
      },
      {
        "@type": "Question",
        "name": "What results should I expect from sermorelin?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Be realistic - the controlled human data are modest. In the main adult trial of GHRH(1-29) (Khorram 1997), IGF-1 rose about 28% and skin thickness increased in both sexes, but lean body mass and quality-of-life gains appeared in men only, and a separate 6-week trial of single nightly dosing found no IGF-1 or body-composition change at all. So expect a modest IGF-1 rise into the upper-normal range, possibly small improvements in body composition, recovery, sleep depth and skin quality over 12-16 weeks, and nothing resembling recombinant HGH or anabolic steroids. Sermorelin is best understood as nudging your own GH secretion back toward a more youthful pattern rather than delivering supraphysiologic GH. Individual response varies widely."
        }
      },
      {
        "@type": "Question",
        "name": "What is the best sermorelin dosage?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "The typical adult protocol is 200-500 mcg subcutaneously once nightly at bedtime. Beginners start at 200-300 mcg to assess tolerance. After 6-12 weeks, responders typically titrate to 300-500 mcg based on IGF-1 response. The single-dose ceiling is around 500 mcg - above that, somatostatin tone prevents further GH release, so higher doses are simply wasted peptide. Some advanced users split the dose into a morning and evening injection, though the bedtime-only approach remains the most common and best-studied. Always dose in a fasted state (3+ hours after last meal) to avoid the insulin-driven somatostatin surge that would blunt GH release."
        }
      },
      {
        "@type": "Question",
        "name": "Can I stack sermorelin with ipamorelin?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Yes - sermorelin + ipamorelin is the classic and most well-established GHRH + GHS combination in the peptide space. The two compounds bind different receptors on the same pituitary somatotrophs (GHRHR and GHS-R1a respectively) and produce a 3-5x amplification of GH pulse amplitude compared to either compound alone (Bowers 1991). Typical stack dose is sermorelin 200-300 mcg + ipamorelin 200-300 mcg in the same subcutaneous injection at bedtime. Ipamorelin's selectivity - it does not elevate cortisol, prolactin, or ACTH - makes it the cleanest ghrelin mimetic to pair with sermorelin. See ipamorelin for full details."
        }
      },
      {
        "@type": "Question",
        "name": "Is sermorelin still FDA approved?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Sermorelin acetate received FDA approval in 1997 as Geref for evaluation of pediatric growth hormone deficiency. The branded product was discontinued commercially in 2008 due to market factors - not safety or efficacy concerns. The peptide itself remains legally available through 503B compounding pharmacies that produce it for physicians who prescribe it off-label for adult GH optimization. This legal-but-compounded status is similar to many other legacy peptides. Clinical use is supervised by medical professionals, and the quality-controlled compounded version is considered equivalent to the original Geref for pharmacologic purposes."
        }
      },
      {
        "@type": "Question",
        "name": "How long does it take sermorelin to work?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "The GH and IGF-1 response to a single sermorelin injection occurs within minutes - peak serum GH typically occurs 15-30 minutes post-injection. However, the clinically meaningful body composition and subjective effects take 6-16 weeks of consistent nightly dosing to become apparent. IGF-1 stabilizes at its new elevated setpoint around week 4-6. Lean body mass changes are detectable by week 8-12. Sleep quality improvements often show up earliest - many users report enhanced slow-wave sleep within 2-3 weeks of consistent dosing. Skin changes (improved thickness, hydration) take 12-16 weeks to measure but are usually subjectively noticed earlier."
        }
      },
      {
        "@type": "Question",
        "name": "What are the side effects of sermorelin?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Most side effects are mild and transient. The most common are injection site reactions (erythema, mild itching), facial flushing immediately after injection (fades within 10-20 minutes), and occasionally vivid dreams - which isn't necessarily adverse given that sermorelin improves slow-wave sleep where dreams are consolidated. Less common effects include mild headache, transient hunger (less pronounced than with ghrelin mimetics), and minor fluid retention in the first weeks. Theoretical long-term concerns relate to sustained IGF-1 elevation and cancer risk, though no causal link has been demonstrated in trials to date. Stop if you develop persistent joint pain, carpal tunnel symptoms, or peripheral edema - these suggest IGF-1 is too high."
        }
      },
      {
        "@type": "Question",
        "name": "Does sermorelin cause weight loss?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Sermorelin is not primarily a weight-loss compound. It produces modest reductions in visceral and subcutaneous fat over 12-16 weeks - typically 1-3% body fat in responders - alongside lean mass gains of similar magnitude. Users looking for dramatic weight loss should consider GLP-1 receptor agonists like semaglutide, tirzepatide, or retatrutide. Sermorelin is better understood as a body-composition-optimization tool that modestly improves the fat-to-lean ratio rather than a fat-loss drug. If visceral adiposity specifically is the target, tesamorelin has FDA-approved trial data showing roughly 18% VAT reduction over 26 weeks, which is substantially more aggressive than sermorelin achieves."
        }
      },
      {
        "@type": "Question",
        "name": "Where can I buy sermorelin legally?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "In the United States, sermorelin can be prescribed legally by licensed physicians and dispensed through 503B compounding pharmacies. This is the proper legal pathway - the prescribing physician oversees dosing, labs, and safety monitoring. There is also a gray-market research-chemical supply chain outside of medical oversight, but this path carries significant quality-control, sterility, and legal risk. Prescribed compounded sermorelin through a qualified clinic is the only path we recommend. For a curated list of peptide-friendly clinical practices and reliable compounded-peptide pharmacies, see our best vendors guide for 2026."
        }
      }
    ]
  },
  {
    "@context": "https://schema.org",
    "@type": "Organization",
    "@id": "https://www.bodyhackguide.co#organization",
    "name": "BodyHackGuide",
    "alternateName": "BHG",
    "url": "https://www.bodyhackguide.co",
    "logo": {
      "@type": "ImageObject",
      "url": "https://www.bodyhackguide.co/logo.png",
      "width": 512,
      "height": 512
    },
    "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. We earn a commission on purchases through some of our links.",
    "foundingDate": "2024",
    "founder": {
      "@id": "https://www.bodyhackguide.co/about#person"
    },
    "sameAs": [
      "https://reddit.com/r/BodyHackGuide",
      "https://reddit.com/r/BrainHackGuide",
      "https://reddit.com/r/Biohackingher",
      "https://discord.gg/Mhq5UdRYBA"
    ],
    "knowsAbout": [
      "Peptide research",
      "Nootropic research",
      "Biohacking",
      "Compound dosing",
      "Vendor transparency"
    ],
    "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards",
    "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards",
    "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards"
  }
]
```